Single-cell Analysis Market - Growth And Key Players Analysis And Forecast

By Author: robert henric
Total Articles: 492
Comment this article

The report “Single-cell Analysis Market by Cell Type (Human, Animal, Microbial), Product (Consumables, Instruments), Technique (Flow Cytometry, NGS, PCR, Mass Spectrometry, Microscopy), Application (Research, Medical Application), End User – Global Forecasts to 2025″, is projected to reach USD 5.6 billion by 2025 from USD 2.1 billion in 2019, at a CAGR of 17.8% during the forecast period.

What Drives the Market Growth?

The growth in single-cell analysis market is driven by technological advancements in single-cell analysis products, increasing government funding for cell-based research, growing biotechnology and bio-pharmaceutical industries, wide applications of single-cell analysis in cancer research, growing focus on personalized medicine, and the increasing incidence and prevalence of chronic and infectious diseases. However, the high cost of single-cell analysis products is expected to restrain the growth of this market to a certain extent during the forecast period.

Don’t miss out on business opportunities in “Single-cell Analysis Market”. Speak to Our Analyst and gain crucial industry ...
... insights that will help your business growth:
https://www.marketsandmarkets.com/speaktoanalystNew.asp?id=171955254

Market Segmentation in Detailed:

Based on application, segmented into research (cancer, immunology, neurology, stem cell, and other research applications) and medical applications (noninvasive prenatal diagnosis, in vitro fertilization, and circulating tumor cell detection). The research applications segment accounted for the largest share of the single cell analysis market in 2018. Increasing government initiatives in stem cell research and the wide usage of single-cell analysis in cancer research are the major factors driving the growth of the research applications segment.

Based on technique, the single-cell analysis market is segmented into flow cytometry, NGS, PCR, microscopy, mass spectrometry, and other techniques. The flow cytometry segment accounted for the largest market share in 2018. The large share of this segment is attributed to the wide usage of flow cytometry in detecting and measuring the physical and chemical characteristics of a population of cells or particles. However, the NGS segment is projected to register the highest growth rate during the forecast period. The high growth of the NGS segment is driven by the increasing application of single-cell analysis products in drug discovery for cancer and other chronic diseases.

Geographical View in-detailed:

The global Single-cell Analysis Market is segmented into five major regions, namely, North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. The Asia Pacific market is anticipated to witness the highest growth during the forecast period. The presence of a large patient population (especially in China and India), increasing investments in R&D, and growth in the outsourcing of drug discovery services to Asian CROs are some of the major factors driving the demand for single-cell analysis consumables and instruments in this regional market.

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=171955254

Global Key Leaders:

Prominent players in the single-cell analysis market include Becton, Dickinson and Company (US), Danaher Corporation (US), Merck Millipore (US), QIAGEN (Netherlands), Thermo Fisher Scientific (US), General Electric Company (US), 10x Genomics (US), Promega Corporation (US), Illumina (US), Bio-Rad Laboratories (US), Fluidigm Corporation (US), Agilent Technologies (US), NanoString Technologies (US), Tecan Group (Switzerland), Sartorius AG (Germany), Luminex Corporation (US), Takara Bio (Japan), Fluxion Biosciences (US), Menarini Silicon Biosystems (Italy), and LumaCyte (US).

Becton, Dickinson and Company held the leading position in the global single-cell analysis market in 2018. The company provides technologically advanced products to hospitals, life science companies, clinical laboratories, and biopharmaceutical and pharmaceutical companies. The company adopts the strategies of product launches and collaborations in order to offer innovative solutions and sustain its leading position in the market. It also focuses on offering solutions and technologies to the research community in order to assist scientists and researchers by developing and manufacturing high-quality diagnostic and imaging products.